APO RESEARCH · REPORT
Artificial Blood Vessel
Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover.
Product & engineering
Understand the product.
Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover.
The current artificial blood vessels are mostly polyester fibers or PTFE fibers woven into the corrugation of the tube has certain porosity. It implanted in the body which can form a layer of fake endometrial. Due to avoiding coagulation and thrombosis, it’s a better solution to the problem of preventing thrombosis. An organism that can be absorbed by the material emerging non-absorbable material and cross-woven, or on the large pore fabric coating absorbable material (e.g. collagen fibers) of the artificial blood vessel, it is easy to fake endometrial growth acceleration effect better.
Selected research
Industry Growth & Trends
Global Artificial Blood Vessel Industry Growth and Trends Forecast to 2032
Market perspective
Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover.
The current artificial blood vessels are mostly polyester fibers or PTFE fibers woven into the corrugation of the tube has certain porosity. It implanted in the body which can form a layer of fake endometrial. Due to avoiding coagulation and thrombosis, it’s a better solution to the problem of preventing thrombosis. An organism that can be absorbed by the material emerging non-absorbable material and cross-woven, or on the large pore fabric coating absorbable material (e.g. collagen fibers) of the artificial blood vessel, it is easy to fake endometrial growth acceleration effect better.
Asia-Pacific is the largest artificial blood vessel market with about 38% market share. North America is follower, accounting for about 30% market share.
Read the full market overview
The key players are Getinge, BD(Bard), Terumo etc. Top 1 company occupied about 45% market share.
Report Scope
This report provides a structured, data-driven view of the global Artificial Blood Vessel market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Artificial Blood Vessel market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Artificial Blood Vessel market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Artificial Blood Vessel.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Artificial Blood Vessel market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Artificial Blood Vessel Market by Company
Getinge
BD (Bard)
Terumo
W. L. Gore
Japan Lifeline
B.Braun
LeMaitre Vascular
Suokang
Chest Medical
Artificial Blood Vessel Segment by Type
EPTFE
Polyethylene Terephthalate
Polyurethane
Others
Artificial Blood Vessel Segment by Application
Aortic Disease
Peripheral Artery Disease
Hemodialysis
Artificial Blood Vessel Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Blood Vessel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Blood Vessel and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Blood Vessel.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Blood Vessel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Artificial Blood Vessel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- EPTFE
- Polyethylene Terephthalate
- Polyurethane
- Others
Applications
- Aortic Disease
- Peripheral Artery Disease
- Hemodialysis
Companies covered
- Getinge
- BD (Bard)
- Terumo
- W. L. Gore
- Japan Lifeline
- B.Braun
- LeMaitre Vascular
- Suokang
- Chest Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Artificial Blood Vessel Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Artificial Blood Vessel Sales Estimates and Forecasts (2021-2032)
- 1.3 Artificial Blood Vessel Market by Type
- 1.3.1 EPTFE
- 1.3.2 Polyethylene Terephthalate
- 1.3.3 Polyurethane
- 1.3.4 Others
- 1.4 Global Artificial Blood Vessel Market Size by Type
- 1.4.1 Global Artificial Blood Vessel Market Size Overview by Type (2021-2032)
- 1.4.2 Global Artificial Blood Vessel Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Artificial Blood Vessel Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Artificial Blood Vessel Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Artificial Blood Vessel Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Artificial Blood Vessel Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Artificial Blood Vessel Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Artificial Blood Vessel Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Artificial Blood Vessel Industry Trends
- 2.2 Artificial Blood Vessel Industry Drivers
- 2.3 Artificial Blood Vessel Industry Opportunities and Challenges
- 2.4 Artificial Blood Vessel Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Artificial Blood Vessel Revenue (2021-2026)
- 3.2 Global Top Players by Artificial Blood Vessel Sales (2021-2026)
- 3.3 Global Top Players by Artificial Blood Vessel Price (2021-2026)
- 3.4 Global Artificial Blood Vessel Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Artificial Blood Vessel Major Company Production Sites & Headquarters
- 3.6 Global Artificial Blood Vessel Company, Product Type & Application
- 3.7 Global Artificial Blood Vessel Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Artificial Blood Vessel Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Artificial Blood Vessel Players Market Share by Revenue in 2025
- 3.8.3 2025 Artificial Blood Vessel Tier 1, Tier 2, and Tier 3
4 Artificial Blood Vessel Regional Status and Outlook
- 4.1 Global Artificial Blood Vessel Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Artificial Blood Vessel Historic Market Size by Region
- 4.2.1 Global Artificial Blood Vessel Sales in Volume by Region (2021-2026)
- 4.2.2 Global Artificial Blood Vessel Sales in Value by Region (2021-2026)
- 4.2.3 Global Artificial Blood Vessel Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Artificial Blood Vessel Forecasted Market Size by Region
- 4.3.1 Global Artificial Blood Vessel Sales in Volume by Region (2027-2032)
- 4.3.2 Global Artificial Blood Vessel Sales in Value by Region (2027-2032)
- 4.3.3 Global Artificial Blood Vessel Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Artificial Blood Vessel by Application
- 5.1 Artificial Blood Vessel Market by Application
- 5.1.1 Aortic Disease
- 5.1.2 Peripheral Artery Disease
- 5.1.3 Hemodialysis
- 5.2 Global Artificial Blood Vessel Market Size by Application
- 5.2.1 Global Artificial Blood Vessel Market Size Overview by Application (2021-2032)
- 5.2.2 Global Artificial Blood Vessel Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Artificial Blood Vessel Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Artificial Blood Vessel Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Artificial Blood Vessel Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Artificial Blood Vessel Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Artificial Blood Vessel Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Artificial Blood Vessel Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Getinge
- 6.1.1 Getinge Company Information
- 6.1.2 Getinge Business Overview
- 6.1.3 Getinge Artificial Blood Vessel Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Getinge Artificial Blood Vessel Product Portfolio
- 6.1.5 Getinge Recent Developments
- 6.2 BD (Bard)
- 6.2.1 BD (Bard) Company Information
- 6.2.2 BD (Bard) Business Overview
- 6.2.3 BD (Bard) Artificial Blood Vessel Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 BD (Bard) Artificial Blood Vessel Product Portfolio
- 6.2.5 BD (Bard) Recent Developments
- 6.3 Terumo
- 6.3.1 Terumo Company Information
- 6.3.2 Terumo Business Overview
- 6.3.3 Terumo Artificial Blood Vessel Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Terumo Artificial Blood Vessel Product Portfolio
- 6.3.5 Terumo Recent Developments
- 6.4 W. L. Gore
- 6.4.1 W. L. Gore Company Information
- 6.4.2 W. L. Gore Business Overview
- 6.4.3 W. L. Gore Artificial Blood Vessel Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 W. L. Gore Artificial Blood Vessel Product Portfolio
- 6.4.5 W. L. Gore Recent Developments
- 6.5 Japan Lifeline
- 6.5.1 Japan Lifeline Company Information
- 6.5.2 Japan Lifeline Business Overview
- 6.5.3 Japan Lifeline Artificial Blood Vessel Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Japan Lifeline Artificial Blood Vessel Product Portfolio
- 6.5.5 Japan Lifeline Recent Developments
- 6.6 B.Braun
- 6.6.1 B.Braun Company Information
- 6.6.2 B.Braun Business Overview
- 6.6.3 B.Braun Artificial Blood Vessel Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 B.Braun Artificial Blood Vessel Product Portfolio
- 6.6.5 B.Braun Recent Developments
- 6.7 LeMaitre Vascular
- 6.7.1 LeMaitre Vascular Company Information
- 6.7.2 LeMaitre Vascular Business Overview
- 6.7.3 LeMaitre Vascular Artificial Blood Vessel Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 LeMaitre Vascular Artificial Blood Vessel Product Portfolio
- 6.7.5 LeMaitre Vascular Recent Developments
- 6.8 Suokang
- 6.8.1 Suokang Company Information
- 6.8.2 Suokang Business Overview
- 6.8.3 Suokang Artificial Blood Vessel Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Suokang Artificial Blood Vessel Product Portfolio
- 6.8.5 Suokang Recent Developments
- 6.9 Chest Medical
- 6.9.1 Chest Medical Company Information
- 6.9.2 Chest Medical Business Overview
- 6.9.3 Chest Medical Artificial Blood Vessel Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Chest Medical Artificial Blood Vessel Product Portfolio
- 6.9.5 Chest Medical Recent Developments
7 North America by Country
- 7.1 North America Artificial Blood Vessel Sales by Country
- 7.1.1 North America Artificial Blood Vessel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Artificial Blood Vessel Sales by Country (2021-2026)
- 7.1.3 North America Artificial Blood Vessel Sales Forecast by Country (2027-2032)
- 7.2 North America Artificial Blood Vessel Market Size by Country
- 7.2.1 North America Artificial Blood Vessel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Artificial Blood Vessel Market Size by Country (2021-2026)
- 7.2.3 North America Artificial Blood Vessel Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Artificial Blood Vessel Sales by Country
- 8.1.1 Europe Artificial Blood Vessel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Artificial Blood Vessel Sales by Country (2021-2026)
- 8.1.3 Europe Artificial Blood Vessel Sales Forecast by Country (2027-2032)
- 8.2 Europe Artificial Blood Vessel Market Size by Country
- 8.2.1 Europe Artificial Blood Vessel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Artificial Blood Vessel Market Size by Country (2021-2026)
- 8.2.3 Europe Artificial Blood Vessel Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Artificial Blood Vessel Sales by Country
- 9.1.1 Asia-Pacific Artificial Blood Vessel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Artificial Blood Vessel Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Artificial Blood Vessel Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Artificial Blood Vessel Market Size by Country
- 9.2.1 Asia-Pacific Artificial Blood Vessel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Artificial Blood Vessel Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Artificial Blood Vessel Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Artificial Blood Vessel Sales by Country
- 10.1.1 South America Artificial Blood Vessel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Artificial Blood Vessel Sales by Country (2021-2026)
- 10.1.3 South America Artificial Blood Vessel Sales Forecast by Country (2027-2032)
- 10.2 South America Artificial Blood Vessel Market Size by Country
- 10.2.1 South America Artificial Blood Vessel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Artificial Blood Vessel Market Size by Country (2021-2026)
- 10.2.3 South America Artificial Blood Vessel Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Artificial Blood Vessel Sales by Country
- 11.1.1 Middle East and Africa Artificial Blood Vessel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Artificial Blood Vessel Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Artificial Blood Vessel Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Artificial Blood Vessel Market Size by Country
- 11.2.1 Middle East and Africa Artificial Blood Vessel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Artificial Blood Vessel Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Artificial Blood Vessel Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Artificial Blood Vessel Value Chain Analysis
- 12.1.1 Artificial Blood Vessel Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Artificial Blood Vessel Production Mode & Process
- 12.2 Artificial Blood Vessel Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Artificial Blood Vessel Distributors
- 12.2.3 Artificial Blood Vessel Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst